
1. sci rep. 2018 sep 14;8(1):13851. doi: 10.1038/s41598-018-32254-z.

susceptibility plasmodium vivax malaria associated darc (duffy antigen)
polymorphisms influenced time exposure malaria.

kano fs(1), de souza am(1), de menezes torres l(1), costa ma(2), souza-silva
fa(1), sanchez bam(3), fontes cjf(4), soares is(5), de brito cfa(1), carvalho
lh(1), sousa tn(6).

author information: 
(1)molecular biology malaria immunology research group, instituto rené
rachou, fundação oswaldo cruz (fiocruz), belo horizonte, minas gerais, brazil.
(2)departamento de engenharia de produção, universidade federal de minas gerais, 
belo horizonte, minas gerais, brazil.
(3)universidade federal de mato grosso, cuiabá, mato grosso, brazil.
(4)hospital julio muller, universidade federal de mato grosso, cuiabá, mato
grosso, brazil.
(5)departamento de análises clínicas e toxicológicas, faculdade de ciências
farmacêuticas, universidade de são paulo, são paulo, sp, brazil.
(6)molecular biology malaria immunology research group, instituto rené
rachou, fundação oswaldo cruz (fiocruz), belo horizonte, minas gerais, brazil.
tais@minas.fiocruz.br.

malaria provided major selective pressure modulated genetic
diversity human genome. variants duffy antigen/receptor for
chemokines (darc) gene probably selected malaria parasites,
particularly fy*o allele, fixed sub-saharan africa confers
resistance plasmodium vivax infection. here, showed influence of
genomic ancestry distribution darc genotypes highly admixed
brazilian population confirmed decreased susceptibility fy*a/fy*o 
genotype clinical p. vivax malaria. fy*b/fy*o individuals associated with
a greater risk developing clinical malaria. remarkable difference among darc
variants concerning susceptibility clinical malaria evident for
individuals less exposed malaria, measured time of
residence endemic area. additionally, found darc-negative and
fy*a/fy*o individuals greater chance acquiring high levels antibodies
against 19-kda c-terminal region p. vivax merozoite surface protein-1.
altogether, results provide evidence darc polymorphisms modulate the
susceptibility clinical p. vivax malaria influence naturally-acquired 
humoral immune response malaria blood antigens, may interfere the
efficacy future vaccine malaria.

doi: 10.1038/s41598-018-32254-z 
pmcid: pmc6138695
pmid: 30218021  [indexed medline]

